Naar www.iknl.nl
- Fertiliteit > Fertiliteitsbehoud bij vrouwen met kanke
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd: 2016-06-10, Versie: 1.0, Verantwoording: NVOG, Type: Landelijke richtlijn

Referentielijst

1 - Bastings L (2014)
Bastings L. Improving female fertility preservation care. Promotieonderzoek Radboud Universiteit Nijmegen 2014. [link]
 
2 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32:1167-70. [link]
 
4 - Aapro (2010)
Aapro, M.S., Challenges in clinical patient management. Cancer investigation, 2010. 28 Suppl 1: p. 14-27.
 
5 - Akashi-Tanaka (2007)
Akashi-Tanaka, S., et al., Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy. Breast, 2007. 16(5): p. 482-8.
 
6 - Ach (2007)
Ach, R.A., et al., Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools. BMC genomics, 2007. 8: p. 148.
 
7 - Abdel-Fatah (2010)
Abdel-Fatah, T.M., et al., The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. The Journal of pathology, 2010. 220(4): p. 419-34.
 
8 - Aapro (2010)
Aapro, M.S., Challenges in clinical patient management. Cancer investigation, 2010. 28 Suppl 1: p. 14-27.
 
9 - Akashi-Tanaka (2007)
Akashi-Tanaka, S., et al., Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy. Breast, 2007. 16(5): p. 482-8.
 
10 - Ach (2007)
Ach, R.A., et al., Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools. BMC genomics, 2007. 8: p. 148.
 
11 - Abdel-Fatah (2010)
Abdel-Fatah, T.M., et al., The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. The Journal of pathology, 2010. 220(4): p. 419-34.
 
12 - Bastings L (2014)
Bastings L. Improving female fertility preservation care. Promotieonderzoek Radboud Universiteit Nijmegen 2014. [link]
 
13 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32:1167-70. [link]
 
14 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503-13. [link]
 
15 - Ethics Committee of American Society for Reproductive Medicine (2013)
Ethics Committee of American Society for Reproductive Medicine. Fertility preservation in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013 Nov;100(5):1224-31. [link]
 
16 - Jeruss JS (2009)
Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. NEJM 2009;360:902-11. [link]
 
17 - Linkeviciute A (2014)
Linkeviciute A, Boniolo G, Chiavari L,et al. Fertility preservation in cancer patients: the global framework. Cancer Treat Rev. 2014 Sep;40(8):1019-27. [link]
 
18 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1;31(19):2500-10. [link]
 
19 - Nisolle M (2000)
Nisolle M, Casanas-Roux F, Qu J, et al. Histologic and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice. Fertil Steril. 2000;74;122-9. [link]
 
20 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23. [link]
 
21 - Von Wolff M (2011)
Von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011 Aug;284(2):427-35. [link]
 
22 - Bozza C (2014)
Bozza C, Puglisi F, Lambertini M, et al. Anti-Müllerian Hormone: determination of ovarian reserve in early breast cancer patients. Endocrine-Related Cancer. 2014;21:R51–R65. [link]
 
23 - Broekmans FJ (2006)
Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685-718. [link]
 
24 - Broekmans FJ (2009)
Broekmans FJ, Soules MR, Fauser BC. Ovarian ageing: mechanisms and clinical consequences. Endocr Rev. 2009;30:465-93. [link]
 
25 - Broer S (2014)
Broer S, Broekmans F, Laven J, et al. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Human Reproduction Update Update. 2014 Sep-Oct;20(5):688-701. [link]
 
26 - Iwase A (2014)
Iwase A, Nakamura T, Nakahara T, et al. Anti-Müllerian Hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2014 Sep 16. [link]
 
27 - Practice Committee of the American Society for Reproductive Medicine (2015)
Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015 Mar;103(3):e9-e17. [link]
 
28 - Anderson RA (2006)
Anderson RA, Themmen AP, Al-Qahtani A, et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006 Oct;21(10):2583-92. [link]
 
29 - Behringer K (2013)
Behringer K, Mueller H, Goergen H, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013 Jan 10;31(2):231-9. [link]
 
30 - Decanter C (2010)
Decanter C, Morschhauser F, Pigny P, et al. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010 Feb;20(2):280-5. [link]
 
31 - Dillon KE (2013)
Dillon KE, Sammel MD, Prewitt M, et al. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013 Feb;99(2):477-83. [link]
 
32 - Gracia CR (2012)
Gracia CR, Sammel MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012 Jan;97(1):134-40. [link]
 
33 - Rosendahl M (2010)
Rosendahl M, Andersen CY, la Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010 Jun;94(1):156-66. [link]
 
34 - Van Beek RD (2007)
Van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Müllerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin’s Lymphoma during Childhood. JCEM 2007;92:3869–74. [link]
 
35 - Apperly (2009)
Apperly, J. CML in pregnancy and childhood. Best pract res clin haematol 2009;455-74. [link]
 
36 - ASCO (2006)
ASCO. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2006 Jun 20 (revised 2013 Jul 1). NGC:010026. [link]
 
37 - Cercek A (2013)
Cercek A, Siegel C, Capanu M, et al. Incidence of Chemotherapy-Induced Amenorrhea
 
38 - in Premenopausal Women Treated With Adjuvant FOLFOX for Colorectal Cancer (2013)
in Premenopausal Women Treated With Adjuvant FOLFOX for Colorectal Cancer. Clinical Colorectal Cancer, 2013, Vol. 12, No. 3, 163-7. [link]
 
39 - Gersheson D (2007)
Gersheson D, Miller A, Champion VL, et al. Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study. J Clinical Oncol. 2007;25:2792-2797. [link]
 
40 - Ruddy K (2014)
Ruddy K, O'Neill A, Miller KD, et al. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014;144:591-597. [link]
 
41 - Satoh T (2015)
Satoh T, Aoki Y, Kasamatsu T, et al. Administration of standard-dose BEP regimen (bleomycin + etoposide + cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015 Feb;51(3):340-51. [link]
 
42 - Swerdlow AJ (2014)
Swerdlow AJ, Cooke R, Bates A, et al. Risk of premature menopause after treatment for Hodgkin's lymphoma. J Natl Cancer Inst. 2014 Aug 19;106(9). [link]
 
43 - Wan J (2015)
Wan J, Gai Y, Li G, et al. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer. 2015 Mar;14(1):31-4. [link]
 
44 - Walshe JM (2008)
Walshe JM, Denduluri N and Swain SM. Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer. J Clin Oncol (2008) 24:5769-5779. [link]
 
45 - Zaza G (2013)
Zaza G, Tomei P, Ria P, et al. Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors. Clin Dev Immunology. 2013. [link]
 
46 - Zhao J (2014)
Zhao J, Liu J, Chen K, et al. What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Res Treat (2014) 145:113–128. [link]
 
47 - Byrne J (1992)
Byrne J, Fears TR, Gail MH, et al. Early menopause in longterm survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788-93. [link]
 
48 - Byrne J (2004)
Byrne J, Fears TR, Mills JL, et al. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42:589-97. [link]
 
49 - Chemaitilly W (2006)
Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:1723–28. [link]
 
50 - Constine LS (1993)
Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;328:87–94. [link]
 
51 - Critchley HO (2005)
Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr. 2005;34:64-8. [link]
 
52 - Faddy MJ (1996)
Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484-6. [link]
 
53 - Holm K (1999)
Holm K, Nysom K, Brocks V, et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant. 1999;23:259-63. [link]
 
54 - Letur-Könirsch H (2005)
Letur-Könirsch H, Lefaix JL, Delanian S. Uterus after irradiation. Gynecol Obstet Fertil. 2005;33:605-9. [link]
 
55 - Nygaard R (1991)
Nygaard R, Clausen N, Siimes MA, et al. Reproduction following treatment for childhood leukemia: A population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol. 1991;19:459–466. [link]
 
56 - Pai HH (2001)
Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;49:1079–1092. [link]
 
57 - Perez CA (2004)
Perez CA and Brady LW. Principles and practice of radiation oncology. Ed: Lippincot Williams & Wilkins. 4th Ed. 2004;0-7917:3525-24. [link]
 
58 - Pérez-Andújar A (2013)
Pérez-Andújar A, Newhauser WD, Taddei PJ, et al. The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation. Phys Med Biol. 2013;58:3107-23. [link]
 
59 - Sanders JE (1988)
Sanders JE, Buckner CD, Amos D, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988;6:813-8. [link]
 
60 - Signorello LB (2006)
Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 2006;98:1453-61. [link]
 
61 - Signorello LB (2010)
Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet. 2010;376:624-30. [link]
 
62 - Sklar CA (2006)
Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98:890-6. [link]
 
63 - Soules MR (1989)
Soules MR, McLachlan RI, Ek M, et al. Luteal phase deficiency: Characterization of reproductive hormones over the menstrual cycle. J Clin Endocrinol Metab. 1989;69:804–12. [link]
 
64 - Teh WT (2014)
Teh WT, Stern C, Chander S, et al. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014. [link]
 
65 - Teoh M (2011)
Teoh M, Clark CH, Wood K, et al. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 2011;84:967-96. [link]
 
66 - Wallace WH (2003)
Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117-21. [link]
 
67 - Wallace WH (2005)
Wallace WH, Thomson AB, Saran F. et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–44. [link]
 
68 - Wo JY (2009)
Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304-12. [link]
 
69 - Cil AP (2013)
Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492-9. [link]
 
70 - Smitz J (2010)
Smitz J, Dolmans MM, Donnez J, et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010 Jul-Aug;16(4):395-414. [link]
 
71 - Telfer EE (2013)
Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99(6):1523-33. [link]
 
72 - Vanacker J (2011)
Vanacker J, Camboni A, Dath C, et al. Enzymatic isolation of human primordial and primary ovarian follicles with Liberase DH: protocol for application in a clinical setting. Fertil Steril. 2011 Aug;96(2):379-83. [link]
 
73 - Anderson B (1993)
Anderson B, LaPolla J, Turner D, et al. Ovarian transposition in cervical cancer. Gynecol Oncol. 1993 May; 49(2):206-14. [link]
 
74 - Bisharah M (2003)
Bisharah M and Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003 Feb;188(2):367-70. [link]
 
75 - Buekers TE (2001)
Buekers TE, Anderson B, Soresky JI, et al. Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol. 2001 Jan;80(1):85-8. [link]
 
76 - Chambers SK (1991)
Chambers SK, Chambers JT, Kier R, et al. Sequelae of lateral ovarian transposition in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1305-8. [link]
 
77 - Clough KB (1996)
Clough KB, Goffnet F, Labib A, et al. Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases. Cancer. 1996 Jun 15;77(12):2638-45. [link]
 
78 - Feeney DD (1995)
Feeney DD, Moore DH, Look KY, et al. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol. 1995 Jan;56(1):3-7. [link]
 
79 - Huang KG (2007)
Huang KG, Lee CL, Tsai CS, et al. A new approach for laparoscopic ovarian transposition before pelvic irradiation. Gynecol Oncol. 2007 Apr;105(1):234-7. [link]
 
80 - Husseinzadeh N (1984)
Husseinzadeh N, Nahhas WA, Velkey DE, et al. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol. 1984 Jul;18(3):373-9. [link]
 
81 - Husseinzadeh N (1994)
Husseinzadeh N, van Aken ML and Aron B. Ovarian transposition in young patients with invasive cervical cancer receiving radiation therapy. Int J Gynecol Cancer. 1994 Jan;4(1):61-65. [link]
 
82 - Irtan S (2013)
Irtan S, Orbach B, Helfre S, et al. Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncology 2013:14:e601-8. [link]
 
83 - Ishii K (2001)
Ishii K, Aoki Y, Takakuwa K, et al. Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer. J Reprod Med. 2001 Apr;46(4):347-52. [link]
 
84 - Lamert G de (2014)
Lamert G de, Haie-Meder, C Guérin F, et al. A new surgical approach of temporary ovarian transposition for children undergoing brachytherapy: technical assessment en dose evaluation. J Ped Surg. 2014;49:1177-80. [link]
 
85 - Lee CT (2005)
Lee CT, Bilton SD, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques? Int J Rad Oncol Biol Phys. 2005;63:362-72.
 
86 - Levine J (2010)
Levine J, Canada A, Stern CJ. Fertlity preservation in adolescents and youg adults with cancer. J Clin Oncol. 2010:28;4831-41. [link]
 
87 - Nagao S (2006)
Nagao S, Fujiwara K, Ishikawa H, et al. Hormonal function after ovarian transposition to the abdominal subcutaneous fat tissue. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):121-4. [link]
 
88 - Owens S (1989)
Owens S, Roberts WS, Fiorica JV, et al. Ovarian management at the time of radical hysterectomy for cancer of the cervix. Gynecol Oncol. 1989 Dec;35(3):349-51. [link]
 
89 - Picone O (2003)
Picone O, Aucouturier JS, Louboutin A, et al. Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literature. Gynecol Oncol. 2003 Aug;90(2):446-9. [link]
 
90 - Ploch E (1988)
Ploch E, Kietlinska Z and Kawozynska M. Evaluation of the hormonal function of transposed ovaries in cervical cancer patients after surgery and pelvic irradiation. Preliminary report. Eur J Gynaecol Oncol. 1988;9(6):479-84. [link]
 
91 - Van Eijkeren M (1999)
Van Eijkeren M, van der Wijk I, El Sharouni SY, et al. Benefits and side effects of lateral ovarian transposition (LOT) performed during radical hysterectomy and pelvic lymphadenectomy for early stage cervical cancer. Int J Gynecol Cancer. 1999 Sep;9(5):396-400. [link]
 
92 - Wallace WH (2005)
Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Rad Oncol Biol Phys. 2005;62:738-44. [link]
 
93 - Wu XH (2005)
Wu XH, Li ZT, Huang X, et al. Transposed ovarian function conservation in cervical cancer patients with radiotherapy. Zhonghua Fu Chan Ke Za Zhi. 2005 Apr;40(4):220-2. [link]
 
94 - Yamamoto R (2001)
Yamamoto R, Okamoto K, Yukiharu T, et al. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol. 2001 Aug;82(2):312-6. [link]
 
95 - Badawy A (2009)
Badawy A, Elnashar A, El-Ashry M, et al. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91:694-7. [link]
 
96 - Behringer K (2010)
Behringer K, Wildt L, Mueller H, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2010;21:2052-60. [link]
 
97 - Chen H (2011)
Chen H, Li J, Cui T, et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. The Cochrane database Syst Rev. 2011;Cd008018. [link]
 
98 - Del Mastro L (2014)
Del Mastro L, Ceppi M, Poggio F, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40:675-83. [link]
 
99 - Demeestere I (2013)
Demeestere I, Brice P, Peccatori FA, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol. 2013;31:903-9. [link]
 
100 - Elgindy EA (2013)
Elgindy EA, El-Haieg DO, Khorshid OM, et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet and gynecol. 2013;121:78-86. [link]
 
101 - Gerber B (2011)
Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29:2334-41. [link]
 
102 - Giuseppe L (2007)
Giuseppe L, Attilio G, Edoardo DN, et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007;12:141-7. [link]
 
103 - Karimi-Zarchi M (2014)
Karimi-Zarchi M, Forat-Yazdi M, Vafaeenasab MR, et al. Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosfamide. European journal of gynaecological oncology 2014;35:59-61. [link]
 
104 - Moore HCF (2015)
Moore HCF, Unger JM, Phillips KA, et al. for the POEMS/S0230 Investigators. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy. N Engl J Med 2015; 372:923-932 March 5, 2015DOI: 10.1056/NEJMoa1413204. [link]
 
105 - Munster PN (2012)
Munster PN, Moore AP, Ismail-Khan R, et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012;30:533-8. [link]
 
106 - Song G (2013)
Song G, Gao H, Yuan Z. Effect of leuprolide acetate on ovarian function after cyclophosfamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial. Med Oncol. (Northwood, London, England) 2013;30:667. [link]
 
107 - Sun X (2014)
Sun X, Dongol S, Jiang J, et al. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. Int J Oncol. 2014;44:1335-40. [link]
 
108 - Vitek WS (2014)
Vitek WS, Shayne M, Hoeger K, et al. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. Fertility and sterility 2014. [link]
 
109 - Wang C (2013)
Wang C, Chen M, Fu F, et al. Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis. PloS One. 2013;8:e66360. [link]
 
110 - Waxman JH (1987)
Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol. 1987;19:159-62. [link]
 
111 - Yang B (2013)
Yang B, Shi W, Yang J, et al. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. Breast (Edinburgh, Scotland). 2013;22:150-7. [link]
 
112 - Behringer K (2010)
Behringer K, Wildt L, Mueller H, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin Lymphoma (HL). Final results of a phase II trial from the German Hodgkin Study Group (GHSG). Ann Oncol. 2010 Oct;21(10):2052-60. [link]
 
113 - Behringer K (2005)
Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 2005 Oct 20;23(30):7555-64. [link]
 
114 - Ben-Aharon I (2010)
Ben-Aharon I, Gafter-Gvili A, Leibovici L, et al. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast cancer res. Treat 2010;122:803-11. [link]
 
115 - Chapman RM (1981)
Chapman RM, Sutcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood. 1981 Oct;58(4):849-51. [link]
 
116 - Elis A (2006)
Elis A, Tevet A, Yerushalmi R, et al. Fertility status among women treated for aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Apr;47(4):623-7. [link]
 
117 - Longhi A (2003)
Longhi A, Pignotti E, Versari M, et al. Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep. 2003 Jan-Feb;10(1):151-5. [link]
 
118 - Whitehead E (1983)
Whitehead E, Shalet SM, Blackledge G, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983 Sep 15;52(6):988-93. [link]
 
119 - ASCO (2006)
ASCO. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2006 Jun 20 (revised 2013 Jul 1). NGC:010026. [link]
 
120 - Kuwayama M (2005)
Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005 Sep;11(3):300-8. [link]
 
121 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN et al. American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1;31(19):2500-10. [link]
 
122 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine (ASRM). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2013 Nov;100(5):1214-23. [link]
 
123 - Azim AA (2008)
Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008 Jun 1;26(16):2630-35. [link]
 
124 - Bedoschi GM (2010)
Bedoschi GM, de Albuquerque FO, Ferriani RA, et al. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet, 2010. 27(8): p. 491-4. [link]
 
125 - Cakmak H (2013)
Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril, 2013a. 99(6): p. 1476-84. [link]
 
126 - Cakmak H (2013)
Cakmak H, Katz A, Cedars MI, et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril, 2013b. 100(6): p. 1673-80. [link]
 
127 - Dahhan T (2013)
Dahhan T, Balkenende E, van Wely M, et al. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. Cochrane.Database.Syst.Rev., 2013. 11: p. CD010240. [link]
 
128 - Dolmans MM (2005)
Dolmans MM, Demylle D, Martinez-Madrid B, et al. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005 Apr;83(4):897-901. [link]
 
129 - Kim J (2016)
Kim J, Turan V, Oktay K. Long-term safety of letrozone and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016 Jan 11. [link]
 
130 - Meirow D (2014)
Meirow D, Raanani H, Maman E, et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril. 2014 Aug;102(2):488-95. [link]
 
131 - Oktay K (2005)
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J.Clin.Oncol., 2005. 23(19): p. 4347-4353. [link]
 
132 - Reddy J (2014)
Reddy J, Turan V, Bedoschi G, et al. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist.Reprod.Genet. 2014. [link]
 
133 - Revelli A (2013)
Revelli A, Porcu E, Levi Setti PE, et al. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol, 2013. 29(11): p. 993-6. [link]
 
134 - Von Wolff M (2009)
Von Wolff M, Thaler CJ, Frambach T, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril, 2009. 92(4): p. 1360-5. [link]
 
135 - Courbiere B (2013)
Courbiere B, Decanter C, Bringer-Deutsch S, et al. Emergency IVF for Embryo Freezing to Preserve Female Fertility; Hum Reprod. 2013;28(9):2381-2388. [link]
 
136 - De Vos M (2014)
De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014 Oct 4;384(9950):1302-10. Review. [link]
 
137 - Lawrenz B (2011)
Lawrenz B, Jauckus J, Kupka MS, et al. Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011 Mar;283(3):651-6. [link]
 
138 - Michaan N (2010)
Michaan N, Ben-David G, Ben-Yosef D, et al. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):175-7. [link]
 
139 - Oktay K (2005)
Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005a;23:3858-9. [link]
 
140 - Oktay K (2005)
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005b;23:4347-53. [link]
 
141 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine (ASRM). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23. [link]
 
142 - Rienzi L (2010)
Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010;25:66–73. [link]
 
143 - Courbiere B (2013)
Courbiere B, Decanter C, Bringer-Deutsch S, et al. Emergency IVF for Embryo Freezing to Preserve Female Fertility; Hum Reprod. 2013;28(9):2381-2388. [link]
 
144 - De Vos M (2014)
De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014 Oct 4;384(9950):1302-10. Review. [link]
 
145 - Lawrenz B (2011)
Lawrenz B, Jauckus J, Kupka MS, et al. Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011 Mar;283(3):651-6. [link]
 
146 - Michaan N (2010)
Michaan N, Ben-David G, Ben-Yosef D, et al. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):175-7. [link]
 
147 - Oktay K (2005)
Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005a;23:3858-9. [link]
 
148 - Oktay K (2005)
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005b;23:4347-53. [link]
 
149 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine (ASRM). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23. [link]
 
150 - Rienzi L (2010)
Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010;25:66–73. [link]
 
151 - Bedoschi GM (2010)
Bedoschi GM, de Albuquerque FO, Ferriani RA, et al. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet. 2010;27(8): 491-4. [link]
 
152 - Cakmak H (2013)
Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99(6): 1476-84. [link]
 
153 - Cakmak H (2013)
Cakmak H, Katz A, Cedars MI, et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673-80. [link]
 
154 - Cil AP (2013)
Cil AP, Bang H and Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492-9.e3. [link]
 
155 - Cobo A (2014)
Cobo A, Serra V, Garrido N, et al. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril. 2014;102(4):1006-15.e4. [link]
 
156 - Dahhan T (2013)
Dahhan T, Balkenende E, van Wely M, et al. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. Cochrane Database Syst Rev. 2013;11:CD010240. [link]
 
157 - Glujovsky D (2014)
Glujovsky D, Riestra B, Sueldo C, et al. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev. 2014;9:CD010047. [link]
 
158 - Levi Setti PE (2007)
Levi Setti PE, Porcu E. Patrizio P, et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data 2007-2011. Fertil Steril. 2014;102(1):90-95.e2. [link]
 
159 - Meirow D (2014)
Meirow D, Raanani H, Maman E, et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril. 2014;102(2):488-5.e3. [link]
 
160 - Oktay K (2005)
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347-53. [link]
 
161 - Oktay K (2006)
Oktay K, Cil AP and Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86(1):70-80. [link]
 
162 - Porcu E (2008)
Porcu E, Bazzocchi, A, Notarangelo L, et al. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):529-35. [link]
 
163 - Practice Committees of American Society for Reproductive Medicine (2013)
Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013 Jan;99(1):37-43. [link]
 
164 - Reddy J (2014)
Reddy J, Turan V, Bedoschi G, et al. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J. Assist Reprod Genet. 2014 Jul;31(7):927-2. [link]
 
165 - Revelli A (2013)
Revelli A, Porvu E, Levi Setti PE, et al. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol. 2013;29(11):993-6. [link]
 
166 - Von Wolff M (2009)
Von Wolff M, Thaler CJ, Frambach T, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92(4):1360-65. [link]
 
167 - Feigin E (2007)
Feigin E, Abir R, Fisch B, et al. Laparoscopic ovarian tissue preservation in young patients at risk for ovarian failure as a result of chrmotherapy/irradiation for primary malignancy. J Pediatr Surg. 2007;42:862-4. [link]
 
168 - Mayerhofer K (2010)
Mayerhofer K, Ott J, Nouri K, et al. Laparoscopic ovarian tissue harvesting for cryopreservation: an effective and safe procedure for fertility preservation. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):68-72. [link]
 
169 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100(5):1214-23. [link]
 
170 - Rosendahl M (2008)
Rosendahl M, Andersen C, Ernst E, et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod. 2008;23:2475-83. [link]
 
171 - Schmidt KL (2003)
Schmidt KL, Byskov AG, Nyboe Andersen A, et al . Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 2003;18:1158-1164. [link]
 
172 - Von Wolff M (2011)
Von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011;284(2):427-35. [link]
 
173 - Demeestere I (2006)
Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006;21:2010-4. [link]
 
174 - Donnez J (2004)
Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-10. [link]
 
175 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013; 99(6):1503-13. [link]
 
176 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32:1167-70. [link]
 
177 - Hubinont C (2004)
Hubinont C, Debieve F, Biard JM, et al. Livebirth after cryopreserved ovarian tissue autotransplantation. Lancet. 2004;364:2093. [link]
 
178 - Macklon KT (2014)
Macklon KT, Jensen AK, Loft A, et al. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet. 2014; 31(11):1557-64. [link]
 
179 - Meirow D (2005)
Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318-21. [link]
 
180 - Oktay K (2004)
Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363:837-40. [link]
 
181 - Rosendahl M (2006)
Rosendahl M, Loft A, Byskov AG, et al.Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod. 2006;21:2006-9. [link]
 
182 - Courbiere B (2013)
Courbiere B, Decanter C, Bringer-Deutsch S, et al. French Study Group for Ovarian and Testicular Cryopreservation (GRECOT). Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study. Hum Reprod. 2013 Sep;28(9):2381-8. [link]
 
183 - Imbert R (2014)
Imbert R, Moffa F, Tsepelidis S, et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod. 2014 Sep;29(9):1931-40. [link]
 
184 - Jansen FW (1997)
Jansen FW, Kapiteyn K, Trimbos-Kemper T, et al. Complications of laparoscopy: a prospective multicentre observational study. Br J Obstet Gynaecol. 1997;104:595-600. [link]
 
185 - Somigliana E (2014)
Somigliana E, Peccatori FA, Filippi F, et al. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation. Hum Reprod Update 2014 Nov-Dec;20(6):944-51. [link]
 
186 - The Ethics Committee of the American Society for Reproductive Medicine (2005)
The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622-8. [link]
 
187 - De Wert G (2000)
De Wert G, de Beaufort ID. Cryopreservatie van ovariumweefsel ter discussie. Ned Tijdschr Geneeskd 2000;144:692-94. [link]
 
188 - Provoost V (2014)
Provoost V, Tilleman K, D’Angelo A, et al. Beyond the dichotomy: a tool for distinguishing between experimental, innovative and establisehd treatment. Hum Reprod 2014;29(3):413-417. [link]
 
189 - Olsthoorn Heim ETM (2006)
Olsthoorn-Heim ETM, Wert GMWR de, Winter HB. Evaluatie Embryowet. Den Haag: ZonMw; 2006. [link]
 
190 - Winter H (2012)
Winter H, et al. Evaluatie Wet Donorgegevens Kunstmatige Bevruchting en tweede Evaluatie Embryowet. ZonMw, Den Haag, 2012. [link]
 
191 - NVOG (1999)
NVOG. Hoog-technologisch draagmoederschap. Richtlijn no.18. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie; 1999. [link]
 
192 - De Wert G (2014)
De Wert G, Dondorp W, Shenfield F, et al. Task Force Ethics & Law, ESHRE. Pre-implantation Genetic Diagnosis. Human Reproduction 2014;29 (8):1610-1617. [link]
 
193 - Gezondheidsraad (2006)
Gezondheidsraad. Preïmplantatie genetische diagnostiek en screening. Publicatienr. 2006/01. Den Haag: Gezondheidsraad; 2006. [link]
 
194 - Offit K (2006)
Offit K, Sagi M, Hurley K. Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine. JAMA 2006;296:2727-30. [link]
 
195 - Regeling PGD 2009 (2009)
Regeling PGD 2009: http://www.pgdnederland.nl/sites/pgd/files/bijlage_1-_strct_2009_-42_regeling_pgd.pdf [link]
 
196 - CBO Kwaliteitsinstituut voor de Gezondheidszorg (2003)
CBO Kwaliteitsinstituut voor de Gezondheidszorg. Modelreglement Embryowet. Alphen aan den Rijn: Van Zuiden Communications; 2003. [link]
 
197 - De Die-Smulders C (2013)
De Die-Smulders C, De Wert G, Liebaers I, et al. Reproductive options for prospective parents in families with Huntington’s disease. Hum Reprod Update 2013. [link]
 
198 - NVOG (2010)
NVOG. Modelprotocol Mogelijke morele contra-indicaties bij vruchtbaarheidsbehandelingen 2010 [link]
 
199 - NVOG (2016)
NVOG. Geassisteerde voortplanting met gedoneerde gameten, gedoneerde embryo’s en draagmoederschap, Standpunt in ontwikkeling. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie; 2016.
 
200 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN et al. American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1;31(19):2500-10. [link]
 
201 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23. [link]
 
202 - Brehaut JC (2003)
Brehaut JC, O'Connor AM, Wood TJ, et al. Validation of a decision regret scale. Medical decision making: an international journal of the Society for Medical Decision Making. 2003; 23: 281-92. [link]
 
203 - Letourneau JM (2012)
Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012; 118: 1710-7. [link]
 
204 - O'Connor AM (1995)
O'Connor AM. Validation of a decisional conflict scale. Medical decision making : an international journal of the Society for Medical Decision Making. 1995; 15: 25-30. [link]
 
205 - Peate M (2012)
Peate M, Meiser B, Cheah BC, et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. British journal of cancer. 2012; 106: 1053-61. [link]
 
206 - Bastings L (2014)
Bastings L, Baysal O, Beerendonk CC, et al. Deciding about fertility preservation after specialist counselling. Human reproduction (Oxford, England). 2014; 29: 1721-9. [link]
 
207 - Garvelink MM (2015)
Garvelink MM, Ter Kuile MM, Bakker RM, et al. Women's experiences with information provision and deciding about fertility preservation in the Netherlands: 'satisfaction in general, but unmet needs'. Health expectations: an international journal of public participation in health care and health policy.Health Expert 2015 Oct;18(5):956-68. [link]
 
208 - Garvelink MM (2012)
Garvelink MM, Ter Kuile MM, Louwe LA, et al. A Delphi consensus study among patients and clinicians in the Netherlands on the procedure of informing young breast cancer patients about Fertility Preservation. Acta oncologica (Stockholm, Sweden). 2012; 51: 1062-9. [link]
 
209 - Kent EE (2013)
Kent EE, Smith AW, Keegan TH, Lynch CF, Wu XC, Hamilton AS, Kato I, Schwartz, SM, Harlan LC. Talking About Cancer and Meeting Peer Survivors: Social Information Needs of Adolescents and Young Adults Diagnosed with Cancer. J Adolesc Young Adult Oncol. 2013 Jun;2(2):44-52. [link]
 
210 - Kim J (2013)
Kim J, Deal AM, Balthazar U, at al. Fertility preservation consultation for women with cancer: are we helping patients make high-quality decisions? Reproductive Medicine Onine. 2013; 27: 96-103. [link]
 
211 - Martinez F (2013)
Martinez F, Devesa M, Coroleu B, et al. Cancer and fertility preservation: Barcelona consensus meeting. Gynecological endocrinology. 2013; 29: 285-291. [link]
 
212 - Mersereau JE (2013)
Mersereau JE, Goodman LR, Deal AM, et al. To preserve or not to preserve: how difficult is the decision about fertility preservation? Cancer. 2013; 119: 4044-50. [link]
 
213 - Peate M (2011)
Peate M, Meiser B, Friedlander M, et al. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011; 29: 1670-7. [link]
 
214 - Peate M (2009)
Peate M, Meiser B, Hickey M, et al. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast cancer research and treatment. 2009; 116: 215-23. [link]
 
215 - Peddie VL (2012)
Peddie VL, Porter MA, Barbour R, et al. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJOG : an international journal of obstetrics and gynaecology. 2012; 119: 1049-57. [link]
 
216 - Sansom-Daly UM (2012)
Sansom-Daly UM, Peate M, Wakefield CE, Bryant RA, Cohn RJ. A systematic review. of psychological interventions for adolescents and young adults living with chronic illness. Health Psychol. 2012 May;31(3):380-93. [link]
 
217 - Thewes B (2003)
Thewes B, Meiser B, Rickard J, et al. The fertility and menopause-related information needs of younger women" with a diagnosis of breast cancer: A qualitative study. "Psycho-oncology. 2003; 12: 500-11". [link]
 
218 - Thewes B (2005)
Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause-related information" needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology. 2005; 23:00 5155-65. [link]
 
219 - Warner EL (2016)
Warner EL, Kent EE, Trevino KM, et al. Social well-being among adolescents and young adults with cancer: A systematic review. Cancer. 2016 Feb 5. [link]
 
220 - MacKie RM (1999)
MacKie RM. Pregnancy and exogenous hormones in patients with cutaneous malignant melanoma. Curr Opin Oncol 1999 Mar: 11(2): 129-31. [link]
 
221 - Boss EA (2005)
Boss EA, van Golde RJ, Beerendonk CC, et al. Pregnancy after radical trachelectomy: a real option? Gynecol Oncol. 2005 Dec: 99(3Suppl 1):S152-6 [link]
 
222 - Disaia PJ
Disaia PJ and Creasman WT. Clinical Gynecological Oncology. St Louis C.V., Mosby Company 2002, USA. [link]
 
223 - Pareja R (2013)
Pareja R, Rendón GJ, Sanz-Lomana CM, et al. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy: a systematic literature review. Gynecol Oncol 2013; 131: 77-82. [link]
 
224 - Plante M (2013)
Plante M. Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy. Int J Gynecol Cancer. 2013 Jul;23(6):982-9. [link]
 
225 - Schneider A (2012)
Schneider A, Erdemoglu E, Chiantera V, et al. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. Int J Gynecol Cancer. 2012 May;22(4):659-66. doi: 10.1097/IGC.0b013e3182466a0e. [link]
 
226 - Brännström M (2015)
Brännström M, Johannesson L, Bokström H, et al. Livebirth after uterus transplantation. Lancet. 2015 Feb 14;385(9968):607-16. [link]
 
227 - Disaia PJ (2002)
Disaia PJ and Creasman WT. Clinical Gynecological Oncology. St Louis C.V., Mosby Company 2002, USA. [link]
 
228 - Frumovitz M (2006)
Frumovitz M, Gershenson DM,. Fertility-sparing therapy for young womaen with endometrial cancer. Expert Rev Anticancer Ther. 2006 Jan:6(1):27-32. [link]
 
229 - Gunderson CC (2012)
Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012 May;125(2):477-82. [link]
 
230 - Mazzon I (2010)
Mazzon I, Corrado G, Masciullo V, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010 Mar 1;93(4):1286-9. [link]
 
231 - Park JY (2002)
Park JY, Kim DY, Kim JH, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer. 2013 Mar;49(4):868-74. [link]
 
232 - Ushijima K (2007)
Ushijima K,Yahata H, Yoshikawa H et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogestrerone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007 Jul 1: 25(19):2798-803. [link]
 
233 - Alvarez M (2014)
Alvarez M, Sole M, Devesa M, et al. Live birth using vitrified–warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online 2014;28:663-8. [link]
 
234 - Ditto A (2014)
Ditto A, Bogani G, Martinelli F, et al. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 2014;25:320-7. [link]
 
235 - Kajiyama H (2011)
Kajiyama H, Shibata K, Mizuno M, et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer 2011;105:1288-1294. [link]
 
236 - Satoh T (2010)
Satoh T, Hatae M, Watanabe Y, et al. Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection. JCO 2010;28:1727-32. [link]
 
237 - Satoh T (2015)
Satoh T, Aoki Y, Kasamatsu T, et al. Administration of standard-dose BEP regimen bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015 Feb;51(3):340-51. [link]
 
238 - Weinberg LE (2011)
Weinberg LE, Lurain JR, Singh DK, et al. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol. 2011;121(2):285-9. [link]
 
239 - Wright JD (2009)
Wright JD, Shah M, Mathew L, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer 2009;115:4118-26. [link]
 
240 - Serkies K. Wysocka B (2002)
Serkies K. Wysocka B, Emerich J, et al. Salvage hemipelvis radiotherapy with fertility preservation in an adolescent with recurrent vulvar carcinoma. Gynecol Oncol. 2002:85:381–3. [link]
 
241 - Solooja N (1994)
Solooja N, Chatterjee R, McMillan K et al. Succesfull pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. Bone Marrow Transplant 1994: 13(4): 431-5. [link]
 
242 - Apperly (2009)
Apperly, CML in pregnancy and childhood. Best pract res clin hematol 2009 455-474. [link]
 
243 - Conchon M (2009)
Conchon M, Sanabani SS, Bendit I, et al. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2009;2:42.24. [link]
 
244 - Conchon M (2010)
Conchon M, Sanabani SS, Serpa M, et al. Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy. Adv Hematol 2010;2010:136252. Epub 2010 Mar 7. [link]
 
245 - Janssen J (2013)
Janssen J, Thielen N en Ossenkoppele GJ. Chronic myeloid leukemia and pregnancy. Ned Tijdschr Hematol 2013;10:268-72.
 
246 - Mahon FX (2010)
Mahon FX, Rea D, Guilhot J, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010;11:1029-35. [link]
 
247 - Thielen N (2013)
Thielen N, Van der Holt B, Cornelissen J, et al. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journa]l of Cancer (2013) 49, 3242– 3246. [link]
 
248 - Ossenkoppele GJ (2011)
Ossenkoppele GJ, Janssen JJ, Posthuma EF et al., namens de HOVON Leukemiewerkgroep. Aanbevelingen voor de behandeling van chronische myeloïde leukemie 2011. Nederlands tijdschr Hematol 2011; 8:237-247. [link]
 
249 - Behringer K (2013)
Behringer K, Mueller H, Goergen H et al. Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials. 2013 J Clin Oncol. 31:231-239. [link]
 
250 - Hodgson DC (2007)
Hodgson DC, Pintillie M, Gitterman L et al. Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 2007 Mar; 25(1):11-5. [link]
 
251 - Viviani S (2011)
Viviani S, Zinzani PL, Rambaldi A, et al. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. N Engl J Med. 2011 Jul 21;365(3):203-12. [link]
 
252 - Salooja N (1994)
Salooja N, Chatterjee R, McMillan AK et al. Succesfull pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. Bone Marrow Transplant 1994; 13(4): 431-5. [link]
 
253 - Azim Jr A (2011)
Azim Jr A, Santoro A, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies. European journal of cancer 47 (2011) 74-83. [link]
 
254 - Canada AL (2012)
Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 2012;21:134-3. [link]
 
255 - Cvancarova M (2009)
Cvancarova M, Samuelsen SO, Magelssen H, et al. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J.Clin Oncol 2009;2:334-43. [link]
 
256 - Gorman JR (2012)
Gorman JR, Bailey S, Pierce JP, et al. How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv 2012: 6:200-9. [link]
 
257 - Gorman JR (2015)
Gorman JR, Su HI, Roberts SC, et al. Experiencing reproductive concerns as a female survivor is associated with depression. Cancer 2015;121:935-42. [link]
 
258 - Green DM (2009)
Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report form the childhood cancer survivor study. J Clin Oncol. 2009;27:2677-85. [link]
 
259 - Howard-Anderson J (2012)
Howard-Anderson J, Ganz PA, Bower JE, et al. Quality of life, fertrility concerns, and behavioral outcomes in younger breast cancer survivors; a systemic review. J Natl Cancer Inst 2012;104:386-405. [link]
 
260 - Kent EE (2012)
Kent EE, Arora NK, Rowland JH, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns 2012;89:345-52. [link]
 
261 - Knapp CA (2011)
Knapp CA, Quinn GP, Murphy D. Assessing the reproductive concerns of children and adolescents with cancer: challenges and potential solutions. J Adolesc Young Adult Oncol 2011;1:31-35. [link]
 
262 - Letourneau JM (2012)
Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012;118:1710-7. [link]
 
263 - Madanat LM (2008)
Madanat LM, Malila N, Dyba T, et al. Probability of parenthood after early onset cancer: a population-based study. Int J Cancer. 2008 Dec 15;123(12):2891-8. [link]
 
264 - Murphy D (2013)
Murphy D, Orgel E, Termuhlen A, et al. Why health care providers should focus on the fertility of AYA cancer survivors: it’s not too late! Front Oncol 2013;3:1-7. [link]
 
265 - Reulen RC (2009)
Reulen RC, Zeegers MP, Wallace WH, et al. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2239-47. [link]
 
266 - SKION (2010)
SKION. Richtlijn Follow-up na kinkerkanker. 2010. [link]
 
267 - Sklar CA (2006)
Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006 Jul 5;98(13):890-6. [link]
 
268 - Syse A (2007)
Syse A, Kravdall, Tretli S. Parenthood after cancer – a population-based study. Psychooncology 2007; 16:920-7. [link]
 
269 - Thewes B (2005)
Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol. 2005;23:5155-65. [link]
 
270 - Treves R (2014)
Treves R, Grynberg M, Parco SI, et al. Female fertility preservation in cancer patients: an instrumental tool for the envisioning a postdisease life. Future Oncol. 2014;10:969-74. [link]
 
271 - Zebrack BJ (2004)
Zebrack BJ, Casillas J, Nohr L, et al. Fertility issues for young adult survivors of childhood cancer. Psychooncology 2004; 13: 689-99. [link]
 
272 - Bastings L (2014)
Bastings L, Baysal Ö, Beerendonk CC, et al. Deciding about fertility preservation after specialist counseling. Human Reproduction 2014;29:1721-9. [link]
 
273 - Crawshaw MA (2010)
Crawshaw MA & Sloper P. Swimming against the tide, the influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. European Journal of Cancer care, 2010: 19; 610-620. [link]
 
274 - Peate M (2009)
Peate M, Meiser B, Hickey M, et al. The fertility related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast cancer res treat 2009;116:215-223. [link]
 
275 - Rosen A (2009)
Rosen A, Rodrigues-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs 2009; 25:268-277. [link]
 
276 - Ruddy KJ (2011)
Ruddy KJ, Gelber S, Ginsburg ES, et al. Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause 2011;18:105-108. [link]
 
277 - Treves R (2014)
Treves R, Grynberg M, Parco SI, et al. Female fertility preservation in cancer patients: an instrumental tool for the envisioning a postdisease life. Future Oncol. 2014;10:969-74. [link]
 
278 - Wenzel L (2005)
Wenzel L, Doan-Ates A, Habbal R, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr 2005:94-98. [link]
 
279 - Goncalves V (2014)
Goncalves V, Sehovic I, Quinn G. Childbearing attitudes and decisions of young breast cancer survivors: a systematic review. Human Reproduction Update 2014;20:279-92. [link]
 
280 - Dudzinski DM (2004)
Dudzinski DM. Ethical issues in fertility preservation for adolescent cancer survivors: oöcyte and ovarian tissue preservation. J Pediatric Adolesc Gynaecol 2004;17:97-102. [link]
 
281 - Green DM (2002)
Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survival Study. Am J Obstet Gynecol 2002;187:1070-80. [link]
 
282 - Meistrich ML (2002)
Meistrich ML, Byrne J. Genetic disease in offspring of long-term survivors of childhood cancer treated with potentially mutagenic therapies. Am J Hum Genet 2002;70;1069-71. [link]
 
283 - Reinmuth S (2008)
Reinmuth S, Liebeskind AK, Wickmann L, Bockelbrink A, Keil T, Henze G, Borgmann A. Having children after surviving cancer in childhood or adolescence - results of a Berlin survey. Klin Padiatr. 2008;220:159-65. [link]
 
284 - Ringbäck Weitoft G (2003)
Ringbäck Weitoft G, Hjern A, Haglund B, et al. Mortality, severe morbidity and injury in children living with single parents in Sweden: a population based study. Lancet 2003;361:289-95. [link]
 
285 - Sankila R (1998)
Sankila R, Olsen JH, Anderson H, et al. Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med 1998;338;1339-44. [link]
 
286 - Schover LR (1999)
Schover LR, Rybicki LA, Martin BA, et al. Having children after cancer: a pilot survey of survivors’ attitudes. Cancer 1999:86:697-709. [link]
 
287 - Schover LR (2002)
Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility and sperm banking in young male survivors. J Clin Onc. 2002;20:1880-9. [link]
 
288 - Swerdlow AJ (1996)
Swerdlow AJ, Jacobs PA, Marks A, et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br J Cancer 1996;74;291-6. [link]
 
289 - Wallace WHB (2005)
Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6:209-18. [link]
 
290 - Cardous-Ubbink MC (2010)
Cardous-Ubbink MC, Geenen MM, Schade KJ, et al. Hypertension in long-term survivors of childhood cancer: a nested case-control study. Eur J Cancer. 2010 Mar;46(4):782-90. [link]
 
291 - Critchley HO (1999)
Critchley HO. Factors of importance for implantation and problems after treatment for childhood cancer. Med Pediatr Oncol 1999;33:9-14. [link]
 
292 - Green DM (2002)
Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002;187:107-80. [link]
 
293 - Kremer LC (2004)
Kremer LC, Caron HN. Anthracycline cardiotoxicity in children. N Engl J Med. 2004 Jul 8;351(2):120-1.
 
294 - Lipshultz SE (2014)
Lipshultz SE, Karnik R, Sambatakos P, et al. Anthracycline-related cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol. 2014 Jan;29(1):103-12. [link]
 
295 - Madanat-Harjuoja LM (2010)
Madanat-Harjuoja LM, Malila N, Lahteenmaki P, et al. Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer. Int J Cancer 2010;127:1669-79. [link]
 
296 - Oeffinger KC (2004)
Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004; 54;208-36. [link]
 
297 - Prins M (2009)
Prins M, van Rosmalen J, Scherjon S, et al. Ziekten en afwijkingen die de zwangerschap compliceren. In: praktische verloskunde. 2009 Bohn Stafleu van Loghum; Hoofdstuk 9:249-81. [link]
 
298 - Signorello LB (2006)
Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 2006;98:1453-61. [link]
 
299 - Tan TC (2015)
Tan TC, Neilan TG, Francis S, et al. Anthracycline-Induced Cardiomyopathy in Adults. Compr Physiol. 2015 Jul 1;5(3):1517-40. [link]
 
300 - Winther JF (2008)
Winther JF, Boice JD Jr, Svendsen AL, et al. Spontaneous abortion in a Danish populationbased cohort of childhood cancer survivors. J Clin Oncol. 2008;26:4340-6. [link]
 
301 - Bozza C (2014)
Bozza C, Puglisi F, Lambertini M. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients. Endocrine-Related Cancer (2014) 21, R51–R65. [link]
 
302 - Broekmans FJ (2006)
Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12: 685-718. [link]
 
303 - Broekmans FJ (2009)
Broekmans FJ, Soules MR, Fauser BC. Ovarian ageing: mechanisms and clinical consequences. Endocr Rev 2009;30:465-93. [link]
 
304 - Broer S (2014)
Broer S, Broekmans F, Laven J. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Human Reproduction Update, Vol.20, No.5 pp. 688–701, 2014. [link]
 
305 - Iwase A (2015)
Iwase A, Nakamura T, Nakahara T, et al. Anti-Müllerian Hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015 May;22(5):519-26. [link]
 
306 - Practice Committee of the American Society for Reproductive Medicine (2015)
Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015 Mar;103(3):e9-e17. [link]
 
307 - Anderson R (2011)
Anderson R, Cameron DA. Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. JCEM 2011; 96: 1336-43. [link]
 
308 - Bath LE (2003)
Bath LE, Wallace WHB, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti?Müllerian hormone, inhibin B and ovarian ultrasound Hum. Reprod. (2003) 18 (11): 2368-2374. [link]
 
309 - Lie Fong S (2008)
Lie Fong S, Lugtenburg PJ, Schipper I, et al. Anti-Müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008 Mar;23(3):674-8. [link]
 
310 - Lie Fong S (2009)
Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum. Reprod.(2009) ;24: 982–990. [link]
 
311 - Lutchman Singh K (2007)
Lutchman Singh K, Muttukrishna S, Stein RC, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer. 2007 Jun 18;96(12):1808-16. [link]
 
312 - Partridge A (2010)
Partridge A, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fert. Steril. 2010; 94: 638–644. [link]
 
313 - Su HI (2010)
Su HI, Sammel MD, Green J, et al. Anti-Müllerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 2010; 116 :592-9. [link]
 
314 - Van Beek RD (2007)
Van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Müllerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin’s Lymphoma during Childhood. JCEM. 2007; 92: 3869-74. [link]
 
315 - Behringer K (2013)
Behringer K, Mueller H, Goergen H, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013 Jan 10;31(2):231-9. [link]
 
316 - Hamre H (2012)
Hamre H, Kiserud CE, Ruud E, et al. Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study. Pediatr Blood Cancer. 2012 Aug;59(2):271-7. [link]
 
317 - Nielsen SN (2013)
Nielsen SN, Andersen AN, Schmidt KT, et al. A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod Biomed Online. 2013 Aug;27(2):192-200. [link]
 
318 - Andersen CY (2012)
Andersen CY, Kristensen SG, Greve T, et al. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. 2012 May;8(5):595-608. [link]
 
319 - Janse F (2011)
Janse F, Donnez J, Anckaert E, et al. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J Clin Endocrinol Metab. 2011 Apr;96(4):1136-44. [link]
 
320 - Chuai Y (2012)
Chuai Y, Xu X, Wang A. Preservation of fertility in females treated for cancer. Int J Biol Sci 2012;8(7):1005-12. [link]
 
321 - Dolmans MM (2005)
Dolmans MM, Demylle D, Martinez-Madrid B, et al. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005 Apr;83(4):897-901. [link]
 
322 - Ginsburg ES (2001)
Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. See comment in PubMed Commons belowFertil Steril. 2001;75(4):705-10. [link]
 
323 - Letourneau JM (2011)
Letourneau JM, Melisko ME, Cedars MI, et al. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol 2011;8(1):56-60. [link]
 
324 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015a;32:1167-70. [link]
 
325 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol 2015b;27:222-30. [link]
 
326 - Dittrich R (2015)
Dittrich R, Hackl J, Lotz L, et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015 Feb;103(2):462-8. [link]
 
327 - Donnez J (2011)
Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011;43:437-50. [link]
 
328 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503-13. [link]
 
329 - Donnez J (2014)
Donnez J, Dolmans MM. Transplantation of ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1188-97. [link]
 
330 - Donnez J (2015)
Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol. 2015 Jun;27(3):222-30. [link]
 
331 - Ernst E (2013)
Ernst E, Kjærsgaard M, Birkebæk NH, et al. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013 Mar;49(4):911-4. [link]
 
332 - Grynberg M (2012)
Grynberg M, Poulain M, Sebag-Peyrelevade S, et al. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril. 2012 Jun;97(6):1260-8. [link]
 
333 - Macklon KT (2014)
Macklon KT, Jensen AK, Loft A, et al. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet. 2014 Nov;31(11):1557-64. [link]
 
334 - Simons A (2012)
Nederlands Netwerk Fertiliteitspreservatie, Simons A, Van Echten-Arends J, et al. Cryopreservatie en transplantatie van ovariumweefsel, landelijk protocol, 2012. [link]
 
335 - NVOG (2014)
NVOG. Leidraad nieuwe interventies in de klinische praktijk versie 1.0, 2014. [link]
 
336 - NVOG/KLEM (2015)
NVOG/KLEM. Kwaliteitsnorm Cryopreservatie en transplantatie van ovariumweefsel, 2015. [link]
 
337 - Schmidt KT (2011)
Schmidt KT, Rosendahl M, Ernst E, et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy induced premature ovarian failure: the Danish experience. Fertil Steril. 2011;95:695-701. [link]
 
338 - Stoop D (2014)
Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline. Lancet. 2014 Oct 4;384(9950):1311-9. Review. Erratum in: Lancet. 2014 Dec 13;384(9960):2110. [link]
 
339 - Demeestere I (2009)
Demeestere I, Simon P, Emiliani S, et al. Orthotopic and heterotoopic ovarian tissue transplantation. Hum Reprod Update 2009;15:649-65. [link]
 
340 - Dittrich R (2015)
Dittrich R, Hackl J, Lotz L, et al. Pregnancies and live births after 20 transpantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103:462-8. [link]
 
341 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fer Steril 2013;99:1503-13. [link]
 
342 - Donnez J (2014)
Donnez J, Dolmans MM. Transplantation of ovarian tissue. Best Practice & Research Clinical Obstetrics and Gynaecology 2014;28:1188-97. [link]
 
343 - Jensen AK (2015)
Jensen AK, Kirstensen SG, Macklon KT et al. Outcomes of transplantations of cryopreserved ovarina tissue tot 41 women in Denmark. Hum Reprod 2015;30:2838-45. [link]
 
344 - Kim SS (2012)
Kim SS. Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J Assist Reprod Genet 2012;29:489-93. [link]
 
345 - Macklon KT (2014)
Macklon KT, Kluver Jensen A, Loft A, et al. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet 2014;31:1557-64. [link]
 
346 - Rosendahl M (2006)
Rosendahl M, Loft A, Byskov AG, et al. Biochemical pregnancy after fertilitzation of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: Case report. Human Reproduction 2006;21:2006-9 doi:10.1093/humrep/de1140. [link]
 
347 - Bastings L (2013)
Bastings L, Beerendonk CCM, Westphal JR, et al. Cyropreservation and autotransplantation of ovarian tissue in cancer patients: is it safe? JAYAO 2013a;2(1):31-4. [link]
 
348 - Bastings L (2013)
Bastings L, Beerendonk CCM, Westphal JR, et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update 2013b;19(5):483-506. [link]
 
349 - Dolmans MM (2010)
Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010;116:2908-14. [link]
 
350 - Dolmans MM (2013)
Dolmans MM, Luyckx V, Donnez J, et al. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013a;99(6):1514-22. [link]
 
351 - Dolmans MM (2013)
Dolmans MM, Jadoul P, Gilliaux S, et al. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 2013b;30:305-14. [link]
 
352 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503-13. [link]
 
353 - Kim SS (2001)
Kim SS, Radford J, Harris M, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 2001;16:2056-60. [link]
 
354 - Kim SS (2006)
Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril. 2006;85:1-11. [link]
 
355 - Lee SJ (2006)
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-31. [link]
 
356 - Loren AW (2013)
Loren AW, Mangu PB, Nohr Beck L, et al. Fertility Preservation for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013;31(19):2500-10. [link]
 
357 - McCarville MB (2001)
McCarville MB, Hill DA, Miller BE, et al. Secondary ovarian neoplasms in children: imaging features with histopathologic correlation. Pediatr Radiol 2001;31:358-64. [link]
 
358 - Meirow D (1998)
Meirow D, Ben Yehuda D, Prus D, et al. Ovarian tissue banking in patients with Hodgkin’s disease: is it safe? Fertil Steril. 1998;69:996-8. [link]
 
359 - Peek R (2015)
Peek R, Bastings L, Westphal JR, et al. A preliminary study on a new model system to evaluate tumour-detection and tumour-purging protocols in ovarian cortex tissue intended for fertility preservation. Human Reproduction (in press) 2015 Apr;30(4):870-6. [link]
 
360 - Rosendahl M (2013)
Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 2013;30:11-24. [link]
 
361 - Schröder CP (2004)
Schröder CP, Timmer-Bosscha H, Wijchman JG, et al. An in vitro model for purging of tumour cells from ovarian tissue. Hum Reprod 2004;19:1069-75. [link]
 
362 - Seshadri T (2006)
Seshadri T, Gook D, Lade S, et al. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 2006;94:1007-10. [link]
 
363 - Shaw JM (1996)
Shaw JM, Bowles J, Koopman P, et al. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996;11:1668-73. [link]
 
364 - Sonmezer M (2004)
Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-66. [link]
 
365 - Sonmezer M (2005)
Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005;322:125-32. [link]
 
366 - Stern CJ (2013)
Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod 2013;28(11):2996-9. [link]
 
367 - Stern CJ (2014)
Stern CJ, Gook D, Hale LG, et al. Delivery of twins following heterotopic grafting of frozen-thawed ovarian tissue. Hum Reprod 2014;29(8):1828. [link]
 
368 - The practice committee of the American Society of Reproductive Medicine (2014)
The practice committee of the American Society of Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101(5):1237-43. [link]
 
369 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN,et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1;31(19):2500-10. [link]
 
370 - Brännström M (2015)
Brännström M, Johannesson L, Bokström H, et al. Livebirth after uterus transplantation. Lancet 2015 Feb 14;385(9968):607-16. [link]
 
371 - Azim A (2007)
Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril. 2007;88(3):657-64. [link]
 
372 - NVOG (1999)
NVOG. Richtlijn Hoog-technologisch draagmoederschap.1999. [link]
 
373 - Modelprotocol Embryowet NVOG (2008)
Modelprotocol Embryowet, Kwaliteitsinstituut voor de gezondheidszorg CBO, Utrecht 2003, revisie 2008. www.nvog-documenten.nl. [link]
 
374 - Andersen CY (2015)
Andersen CY, Kristensen SG. Novel use of the ovarian follicular pool to postpone menopause and delay osteoporosis.Reprod Biomed Online. 2015 Aug;31(2):128-31. [link]
 
375 - Canonico M (2007)
Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115:840-5. [link]
 
376 - Canonico M (2010)
Canonico M, Fournier A, Carcaillon L, et al. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol. 2010;30(2):340-5. [link]
 
377 - Carrasquilla (2015)
Carrasquilla, GD; Berglund A, Gigante B, et al. Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study. Menopause 2015;22(6):598-606. [link]
 
378 - Cherry N (2014)
Cherry N, McNamee R, Heagerty A, et al. Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial. BJOG 2014;121:700–5. [link]
 
379 - Cummings SR (2008)
Cummings SR, Ettinger B, Delmas PD, et al. LIFT Trial Investigators. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359(7):697-708. [link]
 
380 - Elias-Smale SE (2015)
Elias-Smale SE, Günal A, Maas AH. Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women. Maturitas 2015;81(3):348-52. [link]
 
381 - Ettinger B (2002)
Ettinger B, Wang SM, Leslie RS, et al. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause. 2012;19(6):610-5. [link]
 
382 - Formoso G (2012)
Formoso G, Perrone E, Maltoni S, et al. Short and long term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev. 2012;2. Review. [link]
 
383 - Goodman MP (2012)
Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt). 2012;21(2):161-9. [link]
 
384 - Gu H (2014)
Gu H, Zhao X, Zhao X, Yang Y, et al. Risk of stroke in healthy postmenopausal women during and after hormone therapy: a meta-analysis. Menopause 2014;21:1204-1210. [link]
 
385 - Kok HS (2006)
Kok HS, van Asselt KM, van der Schouw YT. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47: 1976–83. [link]
 
386 - Lokkegaard E (2006)
Lokkegaard E, Jovanovic Z, Heitmann BL, et al. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas 2006;53(2):226-33. [link]
 
387 - Maas AH (2009)
Maas AH, Franke HR. Women's health in menopause with a focus on hypertension. Neth Heart J. 2009;17(2):68-72. [link]
 
388 - Mikkola TS (2015)
Mikkola TS, Tuomikoski P, Lyytinen H, et al. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause 2015 Sep;22(9):976-83. [link]
 
389 - NVOG richtlijn cardiovasculair risicomanagement na een reproductieve aandoening 2014 (2014)
NVOG richtlijn cardiovasculair risicomanagement na een reproductieve aandoening 2014. [link]
 
390 - Prentice RL (2014)
Prentice RL. Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med. 2014;32(6):419-25. [link]
 
391 - Renoux C (2010)
Renoux C, Dell'Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost 2010;8(5):979-86. [link]
 
392 - Renoux C (2010)
Renoux C, Dell’aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;340:c2519. [link]
 
393 - Roach RE (2013)
Roach RE, Lijfering WM, Helmerhorst FM et al. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. J Thromb Haemost. 2013;11(1):124-31. [link]
 
394 - Roeters van Lennep JE (2014)
Roeters van Lennep JE, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis. Epub 2014. pii: 2047487314556004. Eur J Prev Cardiol. 2016 Jan;23(2):178-86. [link]
 
395 - Rossouw JE (2002)
Rossouw JE, Anderson GL, Prentice RL. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33. [link]
 
396 - Santen RJ (2010)
Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(7 Suppl 1):s1-s66. [link]
 
397 - Smith NL (2014)
Smith NL, Blondon M, Wiggins KL et al. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Intern Med. 2014;174(1):25-31. [link]
 
398 - Stuenkel CA (2012)
Stuenkel CA. Cardiovascular risk and early menopause: Cause or consequence? Menopause 2012; 19: 1067-69. [link]
 
399 - Sweetland S (2012)
Sweetland S, Beral V, Balkwill A, et al. Million Women Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012;10(11):2277-86. [link]
 
400 - Cooper C (1999)
Cooper C, Stakkestad JA, Radowicki S, et al. Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group. Osteoporos Int. 1999;9(4):358-66. [link]
 
401 - Corbelli J (2015)
Corbelli J, Shaikh N, Wessel C, et al. Low-dose transdermal estradiol for vasomotor symptoms: a systematic review. Menopause 2015;22(1):114-21. [link]
 
402 - Cummings SR (2008)
Cummings SR, Ettinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359(7):697-708. [link]
 
403 - Delmas PD (2001)
Delmas PD, Pornel B, Felsenberg D, et al. Three-year follow-up of the use of transdermal 17?-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. Am J Obstet Gynecol, 2001;184:32–40. [link]
 
404 - Ettinger B (2004)
Ettinger B, Ensrud KE, Wallace R. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004;104(3):443-51. [link]
 
405 - Formoso G (2012)
Formoso G, Perrone E, Maltoni S, et al. Short and long term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev. 2012;2. Review. [link]
 
406 - Kenemans P (2009)
Kenemans P, Bundred NJ, Foidart JM, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10(2):135-46. [link]
 
407 - Maclennan AH (2004)
Maclennan AH, Broadbent JL, Lester S, et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;(4):CD002978. [link]
 
408 - Barrett-Connor E (2006)
Barrett-Connor E, Mosca L, Collins Pl. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-137. [link]
 
409 - Daley A (2014)
Daley A, Stokes-Lampard H, Thomas A, et al. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2014;11:CD006108. [link]
 
410 - Dodin S (2013)
Dodin S, Blanchet C, Marc I, et al. Acupuncture for menopausal hot flushes. Cochrane Database Syst Rev. 2013;7:CD007410. [link]
 
411 - Duijts SF (2012)
Duijts SF, van Beurden M, Oldenburg HS. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol. 2012;30(33):4124-33. [link]
 
412 - Leach MJ (2012)
Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;9:CD007244. [link]
 
413 - Lethaby A (2013)
Lethaby A, Marjoribanks J, Kronenberg F, et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013;12:CD001395. [link]
 
414 - Loprinzi CL (2009)
Loprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009;27(17):2831-7. [link]
 
415 - Mann E (2012)
Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13:309–18. [link]
 
416 - Mewes JC1 (2015)
Mewes JC1, Steuten LM, Duijts SF, et al. Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv. 2015;9(1):126-35. [link]
 
417 - Rada G (2010)
Rada G, Capurro D, Pantoja T, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD004923. [link]
 
418 - CBG Tamoxifen
Registratietekst tamoxifen. College ter beoordeling geneesmiddelen. [link]
 
419 - Santen RJ (2015)
Santen RJ, Loprinzi CL, Casper RF. Menopausal hot flashes. UpToDate 2015. [link]
 
420 - Saensak S (2014)
Saensak S, Vutyavanich T, Somboonporn W, Srisurapanont M. Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database Syst Rev. 2014;7:CD008582. [link]
 
421 - Toulis KA (2009)
Toulis KA, Tzellos T, Kouvelas D, et al. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Clin Ther. 2009;31(2):221-35. [link]
 
422 - Vogel VG (2009)
Vogel VG. The NSABP Study of Tamoxifen and Raloxifene (STAR) trial. Expert Rev Anticancer Ther 2009; 9: 51-60. Review. Erratum in: Expert Rev Anticancer Ther 2009; 9: 388. [link]
 
423 - Woods NF (2014)
Woods NF, Mitchell ES, Schnall JG, et al. Effects of mind-body therapies on symptom clusters during the menopausal transition. Climacteric 2014;17(1):10-22. [link]
 
424 - Zhang L (2015)
Zhang L, Pang Y, Shi Y, et al. Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Menopause 2015;22(9):1021-1025. [link]
 
425 - AbdelHafez FF (2010)
AbdelHafez FF, Desai N, Abou-Setta AM, et al. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis. Reprod Biomed Online. 2010; 20(2):209-22. [link]
 
426 - Adviescommissie Vitrificatie (2007)
Adviescommissie Vitrificatie (NVOG/KLEM). Advies vitrificatie van humane oöcyten en embryo’s 2007. Beschikbaar (o.m.) op www.embryologen.nl. [link]
 
427 - Balaban (2012)
Alpha Scientists In Reproductive Medicine (Balaban et al). The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceedings of an expert meeting. Reprod Biomed Online. 2012; 25(2):146-67. [link]
 
428 - Bedoschi G (2013)
Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril. 2013; 99(6):1496-502. [link]
 
429 - Cil AP (2013)
Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492-499. [link]
 
430 - Cobo A (2011)
Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011; 96(2):277-85. [link]
 
431 - Edgar DH (2012)
Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update. 2012;18(5):536-54. [link]
 
432 - Ethics Committee of the American Society for Reproductive Medicine (2005)
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil. Steril. 2005; 83(6): 1622-1628. [link]
 
433 - Ethics Committee of the American Society for Reproductive Medicine (2013)
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013; 100:1224–1231. [link]
 
434 - Kopeika J (2005)
Kopeika J, Zhang T, Rawson DM, Elgar G. Effect of cryopreservation on mitochondrial DNA of zebrafish (Danio rerio) blastomere cells. Mutat Res 2005;570:49–61. [link]
 
435 - Li L (2012)
Li L, Zhang X, Zhao L, et al. Comparison of DNA apoptosis in mouse and human blastocysts after vitrification and slow freezing. Mol Reprod Dev 2012; 79:229–236. [link]
 
436 - Kopeika J (2015)
Kopeika J, Thornhill A, Khalaf Y. The effect of cryopreservation on the genome of gametes and embryos: principles of cryobiology and critical appraisal of the evidence. Hum Reprod Update 2015; 21(2):209-227. [link]
 
437 - Lee SJ (2006)
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients J Clin Oncol. 2006; 24(18): 2917-2931. [link]
 
438 - Levi Setti PE (2007)
Levi Setti PE, Porcu E, Patrizio P, et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007-2011 Fertil Steril. 2014;102(1):90-5. [link]
 
439 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN, et al. Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update J Clin Oncol. 2013; 31(19):2500-10. [link]
 
440 - Paramanantham J (2015)
Paramanantham J, Talmor AJ, Osianlis T, et al. Cryopreserved oocytes: update on clinical applications and success rates. Obstet Gynecol Surv 2015; 70(2):97-114. [link]
 
441 - Schmidt KL (2003)
Schmidt KL, Byskov AG, Nyboe Andersen A, et al. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 2003 18:1158-1164. [link]
 
442 - The Practice Committee of the ASRM (2014)
ASRM: The Practice Committee of the ASRM. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101:1237-43. [link]
 
443 - Campbell BK (2014)
Campbell BK, Hernandez-Medrano J, Onions V, et al. Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries. Hum Reprod. 2014; 29(8):1749-63. [link]
 
444 - Dittrich R (2012)
Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97:387-90. [link]
 
445 - Dolmans MM (2013)
Dolmans MM, Jadoul P, Gilliaux S, et al. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 2013;30:305-14. [link]
 
446 - Donnez J (2013)
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation.Fertil Steril. 2013;99:1503-13. [link]
 
447 - Fauque P (2007)
Fauque P, Ben Amor A, Joanne C, et al. Use of trypan blue staining to assess the quality of ovarian cryopreservation. Fertil Steril. 2007;87:1200-7. [link]
 
448 - Gerritse R (2011)
Gerritse R, Beerendonk CCM, Westphal JR, et al. Glucose/lactate metabolism of cryopreserved intact bovine ovaries as a novel quantitative marker to asses tissue cryodamage. Repr. Biomed. Online 2011;23:755-764. [link]
 
449 - Gosden RG (1994)
Gosden RG, Bard DT, Wade JC, et al. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196oC. Hum Reprod 1994;9:597-603. [link]
 
450 - Greve T (2012)
Greve T, Clasen-Linde E, Andersen MT, et.al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood 2012;123:4311-6. [link]
 
451 - Imhof M (2006)
Imhof M, Bergmeister H, Lipovac M, et al. Othotopic microvasucular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. Fertil Steril. 2006;85:1208-15. [link]
 
452 - Isachenko V (2012)
Isachenko V, Mallmann P, Pterunkina AM, et al. Comparison of in vitro- and chrioallantoi membrane (CAM)-culture systems for cryopreserved medulla-contained human ovarian tissue. PloS One 2012;7:e32549) CAM. [link]
 
453 - Maltaris T (2006)
Maltaris T, Dragonas C, Hoffmann I, et al. Simple prediction of the survival of follicles in cryoreserved human ovarian tissue. J Reprod Dev 2006;52:577-82. [link]
 
454 - Ronn R (2014)
Ronn R, Holzer HE. Oncofertility in Canada: cryopreservation and alternative options for future parenthood. Curr Oncol:2014;21(1):e137-146. [link]
 
455 - Rosendahl M (2011)
Rosendahl M, Schmidt KT, Ernst E, et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 2011;22:162-71. [link]
 
456 - Von Wolff M (2011)
Von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynaecol Obstet 2011;284:427-435. [link]
 
457 - Demeestere I (2006)
Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006;21(8):2010-14. [link]
 
458 - De Vos M (2014)
De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014 4;384(9950):1302-10. [link]
 
459 - Dittrich R (2015)
Dittrich R, Hackl J, Lotz L, et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103(2):462-8. [link]
 
460 - Donnez J (2004)
Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-10. [link]
 
461 - Donnez J (2006)
Donnez J, Dolmans MM, Demylle D, et al. Restoration of ovarian function after orthotopic (intraovarian an periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: Case report. Hum Reprod 2006;21:183-8. [link]
 
462 - Feldschuh J (2005)
Feldschuh J, Brassel J, Duso N, et al. Succesful sperm storage for 28 years. Fertil Steril 2005;84:1017. [link]
 
463 - Macklon KT (2014)
Macklon KT, Jensen AK, Loft A, et al. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet. 2014; 31(11):1557-64. [link]
 
464 - Meirow D (2007)
Meirow D, Levron J, Eldar-Geva T, et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 2007;87:418.e7-418.e15. [link]
 
465 - Oktay K (2000)
Oktay K, Karlikaya G. Ovarian function after transplantation of frozen banked autologous ovarian tissue. N Engl J Med 2000;342(25):1919. [link]
 
466 - Oktay K (2004)
Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-40. [link]
 
467 - Radford JA (2001)
Radford JA, Lieberman BA, Brison DR, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet 2001;357:1172-5. [link]
 
468 - Rosendahl M (2006)
Rosendahl M, Loft A, Byskov AG, et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod 2006;21:2006-9. [link]
 
469 - Schmidt KLT (2005)
Schmidt KLT, Andersen CY, Loft A, et al. Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod 2005;20:3539-46. [link]
 
470 - Wølner-Hanssen P (2005)
Wølner-Hanssen P, Hägglund L, Ploman F, et al. Autotransplantation of cryopreserved ovarian tissue to the right forearm 41/2 years after autologous stem cell transplantation. Acta Obstet Gynecol Scand 2005;84:695-8. [link]
 
471 - Adams E (2013)
Adams E, Hill E, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes. Br J Cancer 2013;108:1602-15. [link]
 
472 - Bastings L (2014)
Bastings L, Baysal O, Beerendonk CC, et al. Referral for fertility preservation counselling in female cancer patients. Hum Reprod. 2014 Oct 10;29(10):2228-37. [link]
 
473 - Dittrich R (2012)
Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97(2):387-90. [link]
 
474 - Goodman LR (2012)
Goodman LR, Balthazar U, Kim J, et al. Trends of socioeconomic disparities in referral patterns for fertility preservation consultation. HumReprod 2012;27:2076–81. [link]
 
475 - Letourneau JM (2012)
Letourneau JM, Smith JF, Ebbel EE, et al. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer 2012;118:4579–88. [link]
 
476 - Loren AW (2013)
Loren AW, Brazauskas R, Chow EJ, et al. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant 2013;48:1091–97. [link]
 
477 - Loren AW (2013)
Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1;31(19):2500-10. [link]
 
478 - Practice Committee of American Society for Reproductive Medicine (2013)
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23. [link]
 
479 - Quinn GP (2009)
Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–5957. [link]
 
480 - Ronn R (2013)
Ronn R, Holzer H. Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol 2013;20:e465-474. [link]
 
481 - Rosendahl M (2011)
Rosendahl M, Schmidt KT, Ernst E, et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 2011 Feb;22(2):162-71. [link]
 
482 - Shimizu C (2013)
Shimizu C, Bando H, Kato T, et al. Physicians’ knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists. Breast Cancer (Auckl) 2013;20:230–40. [link]
 
483 - Vadaparampil S (2008)
Vadaparampil S, Quinn G, King L, et al. Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns 2008;72:402–10. [link]
 
484 - Woodruff TK (2010)
Woodruff TK. The Oncofertility Consortium, addressing fertility in young people with cancer. Nat Rev Clin Oncol 2010;8:466-75. [link]
 
485 - Chemaitilly W (2006)
Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006; 91:1723-8. [link]
 
486 - Cvancarova M (2009)
Cvancarova M, Samuelsen SO, Magelssen H, et al. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J.Clin Oncol 2009; 27: 334-43. [link]
 
487 - De Bruin ML (2008)
De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 2008; 111:101-8. [link]
 
488 - Fornier MN (2005)
Fornier MN, Modi S, Panageas KS, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breastcarcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005; 15;104(8):1575-9. [link]
 
489 - Green DM (2009)
Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report form the childhood cancer survivor study. J Clin Oncol. 2009;27:2677-85. [link]
 
490 - Lee SJ (2006)
Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology Recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-31. [link]
 
491 - Letourneau JM (2012)
Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012;118:1710-7. [link]
 
492 - Letourneau JM (2012)
Letourneau JM, Ebbel EE, Katz PP et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. 2012; Cancer 118:1933-9. [link]
 
493 - Madanat LM (2008)
Madanat LM, Malila N, Dyba T, et al. Probability of parenthood after early onset cancer: a population-based study. Int J Cancer. 2008 Dec 15;123(12):2891-8. [link]
 
494 - Reulen RC (2009)
Reulen RC, Zeegers MP, Wallace WH, et al. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2239-47. [link]
 
495 - Rosenberg SM (2013)
Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013 Jun;5 Suppl 1:S55-61. [link]
 
496 - Sklar CA (2006)
Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006 Jul 5;98(13):890-6. [link]
 
497 - Syse A (2007)
Syse A, Kravdall, Tretli S. Parenthood after cancer – a population-based study. Psychooncology 2007; 16:920-7. [link]
 
498 - Swerdlow AJ (2014)
Swerdlow AJ, Cooke R, Bates A, et al. Risk of premature menopause after treatment for Hodgkin's lymphoma. J Natl Cancer Inst. 2014 Aug 19;106(9). [link]
 
499 - Wan J (2015)
Wan J, Gai Y, Li G, et al. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer. 2015 Mar;14(1):31-4. [link]
 
500 - Cao (2013)

 

Cao DY et al.; China Gynecologic Oncology Group.Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China. Br J Cancer. 2013 Nov 26;109(11):2778-82